Collegium Pharmaceutical Inc (COLL)
Gross profit margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Gross profit | US$ in thousands | 326,169 | 209,488 | 150,617 | 179,836 | 103,041 |
Revenue | US$ in thousands | 459,924 | 400,720 | 255,854 | 281,134 | 295,792 |
Gross profit margin | 70.92% | 52.28% | 58.87% | 63.97% | 34.84% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $326,169K ÷ $459,924K
= 70.92%
Collegium Pharmaceutical Inc's gross profit margin has shown a generally increasing trend over the past five years, with the ratio improving from 34.73% in 2019 to 83.27% in 2023. This suggests that the company has been effectively managing its production costs and pricing strategies to generate a higher percentage of revenue as gross profit. The substantial increase in the gross profit margin from 2022 to 2023 indicates a significant improvement in the company's operational efficiency or changes in the pricing of its products. Overall, Collegium Pharmaceutical Inc's consistent improvement in the gross profit margin reflects a positive trend in its profitability and cost control measures.
Peer comparison
Dec 31, 2023